Schedule 13G ownership disclosure

Sarepta Therapeutics Inc

Security class unavailable · CUSIP: 803607100

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
977,131
Percent of class
1.2400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001020066-21-000014
Form type
SC 13G
Filer
SANDS CAPITAL MANAGEMENT, LLC
CIK
CIK 1020066
Filed
Feb 16, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub